Hundreds of industry leaders voiced support for the FDA after a judge ruled to invalidate the drug mifepristone's approval by the agency.
spoke out against the ruling made by Judge Matthew J. Kacsmaryk of the U.S. District Court for the Northern District of Texas last Friday.In their letter, published by The New York Times, the leaders called for the ruling to be reversed, claiming it “ignores decades of scientific evidence and legal precedent.”
Leaders in the drug industry called for a reversal after a Texas district court judge ruled to invalidate the FDA's approval of the abortion medication mifepristone.The statement, which was signed by heads at Pfizer and Biogen, denounced the decision as an attempt to curtail the FDA’s autonomy, claiming any drug’s approval could be in jeopardy “if courts can overturn drug approvals without regard for science or evidence.
Kacsmaryk ruled that the FDA improperly approved mifepristone for use in 2000, arguing that the agency “manipulated and misconstrued” their studies “to greenlight elective chemical abortions on a wide scale.”The FDA has since defended mifepristone as a “safe and effective” option for early-term abortions.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Republican congresswoman says FDA should ignore ruling suspending abortion drug approval | CNN PoliticsA Republican congresswoman who represents a swing district in South Carolina urged the Food and Drug Administration on Monday to ignore a recent ruling by a federal judge suspending the approval of a medication drug used for abortion.
Read more »
DOJ asks appeals court to stay Texas ruling against FDA abortion drug approvalThe Justice Department asked the U.S. Court of Appeals for the 5th Circuit to stay a Texas judge's order to suspend the Food and Drug Administration's approval of a common abortion drug, asking for intervention no later than Thursday at noon.
Read more »
US FDA advisers to weigh full approval for Eisai-Biogen's Alzheimer's drugThe U.S. Food and Drug Administration (FDA) plans to hold a meeting of its outside experts in June to discuss full approval of the Alzheimer's drug developed by Eisai Co Ltd and Biogen Inc , according to a federal filing on Monday.
Read more »
Texas federal judge halts FDA approval of abortion pill mifepristone; Biden administration filing appealThe FDA approved mifepristone more than 20 years ago.
Read more »